Atlas

Form 483

Annovex Pharma, Inc. Form 483, 2026-06-03

FDA issued a Form 483 to Annovex Pharma, Inc. on 2026-06-03 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Annovex Pharma, Inc. · Lorton, United States · Issued June 3, 2026

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Jun 2026
21 CFR 211.180(e)

Records reviewed annually

Cited by Christina K Theodorou

3 Jun 2026
21 CFR 211.42(c)(10)(vi)

Equipment to control conditions

Cited by Christina K Theodorou

Inspected site

APAnnovex Pharma, Inc.Lorton, United States

Inspection team

CKChristina K Theodorou

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(vi)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere